Literature DB >> 8392548

Comparison of adenosine and muscarinic receptor-mediated effects on protein phosphatase inhibitor-1 activity in the heart.

R C Gupta1, J Neumann, A M Watanabe.   

Abstract

Langendorff-perfused guinea pig ventricles were used to examine the effects of the adenosine agonists, (-)-N-6-phenylisopropyl-adenosine (PIA) and 5'-N-ethylcarboxamidoadenosine and the muscarinic cholinergic agonist, acetylcholine, on the rate of tension development, protein phosphatase inhibitor-1 (PPI-1) activity, and cyclic AMP-dependent protein kinase (PKA) activity ratio. Isoproterenol (10 nM) and forskolin (1 microM) stimulated rate of tension development, PKA activity ratio and PPI-1 activity each approximately 2-fold. Acetylcholine (1 microM) by itself was not effective, but when administered with isoproterenol for forskolin reduced the rate of tension development and PPI-1 activity without decreasing PKA activity ratio. Similarly, both PIA and 5'-N-ethylcarboxamidoadenosine alone were ineffective, but when simultaneously applied with isoproterenol attenuated the isoproterenol-stimulated rate of tension development and PPI-1 activity. PIA reduced PKA activity ratio, whereas 5'-N-ethylcarboxyamidoadenosine failed to do so. However, the effect of PIA on PKA activity ratio was smaller than those seen on rate of tension development and PPI-1 activity. Hence, the present data do not support a cyclic AMP-dependent regulation of PPI-1 activity by adenosine and muscarinic agonists. It is tempting to speculate that adenosine and muscarinic agonists reduce PPI-1 activity by a cyclic AMP-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392548

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Negative chronotropic and inotropic effects exerted by diadenosine hexaphosphate (AP6A) via A1-adenosine receptors.

Authors:  U Vahlensieck; P Bokník; J Knapp; B Linck; F U Müller; J Neumann; S Herzig; H Schlüter; W Zidek; M C Deng; H H Scheld; W Schmitz
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Mechanisms of the contractile effects of flosequinoxan.

Authors:  N Zimmermann; G S Bodor; P Boknik; E Gams; L R Jones; J Neumann; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

3.  Reduced inhibitor 1 and 2 activity is associated with increased protein phosphatase type 1 activity in left ventricular myocardium of one-kidney, one-clip hypertensive rats.

Authors:  Ramesh C Gupta; Sudhish Mishra; Xiao-Ping Yang; Hani N Sabbah
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

4.  Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle.

Authors:  G E Newton; A B Parker; J S Landzberg; W S Colucci; J D Parker
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

Review 5.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

6.  Slowing of shortening velocity of rat cardiac myocytes by adenosine receptor stimulation regardless of beta-adrenergic stimulation.

Authors:  K T Strang; R M Mentzer; R L Moss
Journal:  J Physiol       Date:  1995-08-01       Impact factor: 5.182

7.  Stimulation of protein phosphatases as a mechanism of the muscarinic-receptor-mediated inhibition of cardiac L-type Ca2+ channels.

Authors:  S Herzig; A Meier; M Pfeiffer; J Neumann
Journal:  Pflugers Arch       Date:  1995-02       Impact factor: 3.657

Review 8.  Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization.

Authors:  P V Sulakhe; X T Vo
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

9.  Muscarinic-cholinoceptor mediated attenuation of phospholamban phosphorylation induced by inhibition of phosphodiesterase in ventricular cardiomyocytes: evidence against a cAMP-dependent effect.

Authors:  R C Gupta; J Neumann; A M Watanabe; H N Sabbah
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

10.  A positive inotropic effect of adenosine in cardiac preparations of right atria from diseased human hearts.

Authors:  Ulrich Gergs; Peter Boknik; Wilhelm Schmitz; Andreas Simm; Rolf-Edgar Silber; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.